To further validate this tumour‐promoting effect of IFI16 during cisplatin therapy, we established a subcutaneous implantation tumour model using mouse cervical cancer (U14) cells and conducted additional in vitro experiments. This evidence concerns the gene IFI16 and neoplasm.